Business Description
Founded in 2008 and headquartered in Cambridge, UK, 4basebio PLC develops and produces synthetic DNA and RNA materials along with delivery systems for use in medicines and vaccines across Europe, the United States, and beyond. The company offers a range of specialized DNA products designed for applications such as gene therapy, mRNA production, genome editing, and DNA-based vaccines. It also owns a proprietary delivery platform called Hermes, which transports genetic and protein materials into cells and may serve as a more temperature-stable option compared to conventional fat-based delivery methods.